Notice for sirolimus/rapamycin (AFT Pharmaceuticals Pty Ltd)
Active ingredients
sirolimus/rapamycin
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Topical cream
Indication
Treatment of facial angiofibromas associated with tuberous sclerosis complex
Therapeutic area
Dermatology